Table 1

Baseline demographics and clinical characteristics of hallucinations group
Randomization groups
Characteristics Risperidone (N = 37) Olanzapine (N = 37) Quetiapine (N = 38) Ziprasidone (N = 42) All patients (N = 154)
N % N % N % N % N %
Gender
Male 28 75.7 24 64.9 24 63.2 25 59.5 101 65.6
Antipsychotic naïve 13 36.1 14 37.8 21 55.3 22 52.4 70 45.8
Alcohol last 6 months
None 11 29.7 6 16.2 5 13.2 8 19.5 30 19.6
Misuse 3 8.1 4 10.8 9 23.7 4 9.8 20 13.1
Drugs last 6 months
None 19 52.8 26 70.3 28 73.7 26 63.4 99 65.1
Misuse 11 30.6 6 16.2 5 13.1 9 21.9 31 20.4
Diagnosis1
Schz and rel. 18 52.9 16 44.5 24 63.1 20 51.3 78 53.1
Acute 2 5.9 8 22.2 3 7.9 4 10.3 17 11.6
Drug-induced 8 23.5 4 11.1 6 15.8 5 12.8 23 15.6
Affective 3 8.8 4 11.1 3 7.9 3 7.7 13 8.8
Rest 3 8.7 4 11.1 2 5.2 7 18.0 16 11.0
Mean SD Mean SD/Range Mean SD/Range Mean SD/Range Mean SD
Age 32.9 12.0 30.1 11.9 35.8 12.8 29.1 11.5 31.9 12.2
PANSS Total 76.8 13.5 77.2 14.2 76.2 14.6 74.4 12.8 76.1 13.7
PANSS Positive 20.2 4.6 21.7 4.6 21.0 4.2 20.4 4.6 20.8 4.5
PANSS Negative 21.7 8.0 18.7 7.9 19.8 7.2 19.0 7.0 19.8 7.5
PANSS General 34.8 6.5 36.9 7.8 35.3 7.3 35.0 6.7 35.5 7.1
CDSS 7.2 5.8 7.0 4.5 7.1 4.6 7.6 6.0 7.2 5.2
GAF-F 31.4 5.3 29.3 5.6 30.6 7.3 29.9 6.7 30.3 6.3
CGI 5.3 0.6 5.3 0.7 5.3 0.6 5.1 0.5 5.3 0.6

Notes: N = number of patients; SD = standard deviation; Antipsychotic naïve = No lifetime exposure to antipsychotic drugs before index admission; First admission = Index admission was the first admission to a mental hospital; Misuse = Misuse or dependence according to Drake et al. [15]; Schz and rel. = Schizophrenia and related disorders: Schizophrenia, schizoaffective disorder, acute polymorphic psychotic disorder with symptoms of schizophrenia, acute schizophrenia-like psychotic disorder, delusional disorder; Acute = Acute psychosis other than those categorized under Schz and rel.; Affective = Affective psychosis; Rest = Miscellaneous psychotic disorders. All diagnoses are according to ICD-10; PANSS = the Positive and Negative Syndrome Scale; CDSS = the Calgary Depression Scale for Schizophrenia; GAF-F = the Global Assessment of Functioning, Split Version, Functions scale; CGI = the Clinical Global Impression, Severity of Illness Scale.

1 Patients with missing diagnoses are not included in the list.

Johnsen et al.

Johnsen et al. BMC Psychiatry 2013 13:241   doi:10.1186/1471-244X-13-241

Open Data